Literature DB >> 31642164

Ex Situ Liver Machine Perfusion: The Impact of Fresh Frozen Plasma.

Qiang Liu1, Ahmed Hassan1, Daniele Pezzati1, Basem Soliman1, Laura Lomaglio1, Patrick Grady2, Laurent Del Angel Diaz1, Andrea Simioni1, Shana Maikhor1, John Etterling1, Giuseppe D'Amico1, Giuseppe Iuppa1, Teresa Diago Uso1, Koji Hashimoto1, Federico Aucejo1, Masato Fujiki1, Bijan Eghtesad1, Kazunari Sasaki1, Choon Hyuck David Kwon1, Jacek Cywinski3, Samuel Irefin3, Ana Bennett1, William Baldwin4, Charles Miller1, Cristiano Quintini1.   

Abstract

The primary aim of this single-center, phase 1 exploratory study was to investigate the safety, feasibility, and impact on intrahepatic hemodynamics of a fresh frozen plasma (FFP)-based perfusate in ex situ liver normothermic machine perfusion (NMP) preservation. Using an institutionally developed perfusion device, 21 livers (13 donations after brain death and 8 donations after circulatory death) were perfused for 3 hours 21 minutes to 7 hours 52 minutes and successfully transplanted. Outcomes were compared in a 1:4 ratio to historical control patients matched according to donor and recipient characteristics and preservation time. Perfused livers presented a very low resistance state with high flow during ex situ perfusion (arterial and portal flows 340 ± 150 and 890 ± 70 mL/minute/kg liver, respectively). This hemodynamic state was maintained even after reperfusion as demonstrated by higher arterial flow observed in the NMP group compared with control patients (220 ± 120 versus 160 ± 80 mL/minute/kg liver, P = 0.03). The early allograft dysfunction (EAD) rate, peak alanine aminotransferase (ALT), and peak aspartate aminotransferase (AST) levels within 7 days after transplantation were lower in the NMP group compared with the control patients (EAD 19% versus 46%, P = 0.02; peak ALT 363 ± 318 versus 1021 ± 999 U/L, P = 0.001; peak AST 1357 ± 1492 versus 2615 ± 2541 U/L, P = 0.001 of the NMP and control groups, respectively). No patient developed ischemic type biliary stricture. One patient died, and all other patients are alive and well at a follow-up of 12-35 months. No device-related adverse events were recorded. In conclusion, with this study, we showed that ex situ NMP of human livers can be performed safely and effectively using a noncommercial device and an FFP-based preservation solution. Future studies should further investigate the impact of an FFP-based perfusion solution on liver hemodynamics during ex situ normothermic machine preservation.
Copyright © 2019 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2020        PMID: 31642164     DOI: 10.1002/lt.25668

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  7 in total

Review 1.  Hospital-Based Health Technology Assessment of Machine Perfusion Systems for Human Liver Transplantation.

Authors:  Paolo De Simone; Davide Ghinolfi
Journal:  Transpl Int       Date:  2022-05-27       Impact factor: 3.842

Review 2.  Current review of machine perfusion in liver transplantation from the Japanese perspective.

Authors:  Noboru Harada; Tomoharu Yoshizumi; Masaki Mori
Journal:  Surg Today       Date:  2021-03-22       Impact factor: 2.549

Review 3.  Endogenous memory T cells with donor-reactivity: early post-transplant mediators of acute graft injury in unsensitized recipients.

Authors:  Erik H Koritzinsky; Hidetoshi Tsuda; Robert L Fairchild
Journal:  Transpl Int       Date:  2021-06-29       Impact factor: 3.842

4.  A Systematic Review and Meta-Analysis of Machine Perfusion vs. Static Cold Storage of Liver Allografts on Liver Transplantation Outcomes: The Future Direction of Graft Preservation.

Authors:  Junjun Jia; Yu Nie; Jianhui Li; Haiyang Xie; Lin Zhou; Jun Yu; Shu-Sen Zheng
Journal:  Front Med (Lausanne)       Date:  2020-05-12

5.  Two Compartment Evaluation of Liver Grafts During Acellular Room Temperature Machine Perfusion (acRTMP) in a Rat Liver Transplant Model.

Authors:  Nader Abraham; Min Zhang; Paul Cray; Qimeng Gao; Kannan P Samy; Ryan Neill; Greta Cywinska; JonCarlo Migaly; Riley Kahan; Arya Pontula; Samantha E Halpern; Caroline Rush; Jude Penaflor; Samuel J Kesseli; Madison Krischak; Mingqing Song; Matthew G Hartwig; Justin J Pollara; Andrew S Barbas
Journal:  Front Med (Lausanne)       Date:  2022-02-24

6.  Machine Perfusion in Liver Transplantation: A Systematic Review and Meta-Analysis.

Authors:  Matas Jakubauskas; Lina Jakubauskiene; Bettina Leber; Kestutis Strupas; Philipp Stiegler; Peter Schemmer
Journal:  Visc Med       Date:  2021-11-08

7.  Ex vivo machine perfusion: current applications and future directions in liver transplantation.

Authors:  Julian Michelotto; Joseph M G V Gassner; Simon Moosburner; Vanessa Muth; Madhukar S Patel; Markus Selzner; Johann Pratschke; Igor M Sauer; Nathanael Raschzok
Journal:  Langenbecks Arch Surg       Date:  2020-11-20       Impact factor: 3.445

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.